Evidence map›Paper›PMID 27152521›Full record

ArticlePloS one2016

Complex Behavior of ALDH1A1 and IGFBP1 in Liver Metastasis from a Colorectal Cancer.

Jin Cheon Kim, Ye Jin Ha, Ka Hee Tak, Seon Ae Roh, Chan Wook Kim, Tae Won Kim, Seon-Kyu Kim, Seon-Young Kim, Dong-Hyung Cho, Yong Sung Kim

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Jin Cheon KimDepartment of Surgery, University of Ulsan College of Medicine, Seoul, Korea.
Ye Jin HaDepartment of Surgery, University of Ulsan College of Medicine, Seoul, Korea.
Ka Hee TakDepartment of Surgery, University of Ulsan College of Medicine, Seoul, Korea.
Seon Ae RohDepartment of Surgery, University of Ulsan College of Medicine, Seoul, Korea.
Chan Wook KimDepartment of Surgery, University of Ulsan College of Medicine, Seoul, Korea.
Tae Won KimDepartment of Medicine, University of Ulsan College of Medicine, Seoul, Korea.
Seon-Kyu KimMedical Genomics Research Center, Korea Research Institute of Bioscience & Biotechnology, Daejeon, Korea.
Seon-Young KimMedical Genomics Research Center, Korea Research Institute of Bioscience & Biotechnology, Daejeon, Korea.
Dong-Hyung ChoInstitute of Innovative Cancer Research, Asan Medical Center, Seoul, Korea.
Yong Sung KimInstitute of Innovative Cancer Research, Asan Medical Center, Seoul, Korea.
University of Ulsan · KRKorea Research Institute of Bioscience and Biotechnology · KRAsan Medical Center · KRUlsan College · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Using our data set (GSE50760) previously established by RNA sequencing, the present study aimed to identify upregulated genes associated with colorectal cancer (CRC) liver metastasis (CLM) and verify their biological behavior. The potential roles of candidate genes in tumors were assessed using cell proliferation and invasion assays. Tissue samples were collected from 18 CRC patients with synchronous CLM and two CRC cell lines (SW480 and SW620) were used for transfection and cloning. The roles of the genes identified in CLM were verified using immunohistochemistry in 48 nude mice after intrasplenic transplantation of CRC cells. mRNA and protein expression was determined by quantitative real-time reverse transcription polymerase chain reaction and western blot, respectively. Nine genes were initially selected according to the relevance of their molecular function and biological process and, finally, ALDH1A1 and IGFBP1 were chosen based on differential mRNA expression and a positive correlation with protein expression. The overexpression of ALDH1A1 and IGFBP1 significantly and time-dependently decreased cell proliferation (p ≤ 0.001-0.003) and suppressed invasiveness by ≥3-fold over control cells (p < 0.001) in the SW480 cell line, whereas they had a slight effect on reducing SW620 cell proliferation. The protein expression levels of E-cadherin, N-cadherin, claudin-1, and vimentin were significantly higher in CLM than in primary tumor tissues (p < 0.05). However, the cadherin switch, namely, N-cadherin overexpression with reduced E-cadherin expression, was not observed in CLM tissues and transfected CRC cells. Irrespective of reduced proliferation and invasion found on in vitro cell assays, persistent overexpression of β-catenin, vimentin, and ZO-1 in IGFBP1-overexpressing SW480 cells possibly contributed to CLM development in mice implanted with IGFBP1-overexpressing SW480 cells (CLM occurrences: SW480/IGFBP1-transfected mice vs. SW480/vector- and SW480/ALDH1A1-transfected mice, 4/8 vs. 0/10, p = 0.023). In conclusion, ALDH1A1 and IGFBP1 are differentially overexpressed in CLM and may play a dual role, functioning as both tumor suppressors and metastasis promoters in CRC.

Indexed as

Aldehyde DehydrogenaseAldehyde Dehydrogenase 1 FamilyAnimalsCell Line, TumorCell ProliferationColorectal NeoplasmsHeterograftsHumansInsulin-Like Growth Factor Binding Protein 1Liver NeoplasmsMiceMice, Inbred BALB CMice, NudeRetinal DehydrogenaseAldehyde DehydrogenaseAldehyde Dehydrogenase 1 FamilyALDH1A1 protein, humanIGFBP1 protein, humanInsulin-Like Growth Factor Binding Protein 1Retinal Dehydrogenase

Identifiers

PMID27152521
PMCPMC4859559
OpenAlexW2347060096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.